A multicenter trial of alogliptin for the safety and efficacy on glycemic control in Japanese type 2 diabetic patients undergoing hemodialysis.
Phase of Trial: Phase II
Latest Information Update: 12 May 2016
At a glance
- Drugs Alogliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 03 Aug 2011 New trial record